An anti-inflammatory nasal spray reduces the severity of symptoms in a mouse model of multiple sclerosis (MS), suggesting it may also treat the condition in humans.
Multiple sclerosis occurs when the immune system mistakenly damages myelin, the protective membrane of nerves. This causes vision problems, difficulty walking, and other symptoms.
Most people with MS experience flare-ups in which myelin is damaged and symptoms worsen, followed by a recovery period in which myelin regenerates. This is known as…
Source: www.newscientist.com